BCL2L1 and hypertensive disorder: We identified that EGCG treatment activated the Bcl-2 family-related pro-survival pathway against early aged hypertension in the cerebral cortex, as evidenced by the up-regulated levels of Bcl-2, Bcl-xL, pBad, and 14-3-3.